Conference Coverage
Conference Coverage
05/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers investigated semaglutide’s impact on weight-related muscle loss and its potential impact on spinal surgical outcomes, specifically transforaminal lumbar interbody fusion.
05/22/2024
Conference Coverage
Conference Coverage
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.
05/16/2024
Conference Coverage
Conference Coverage
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.
05/16/2024
Conference Coverage
Conference Coverage
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.
05/16/2024
Conference Coverage
Conference Coverage
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.
05/16/2024
Conference Coverage
Conference Coverage
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.
05/16/2024
Conference Coverage
Conference Coverage
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.
05/16/2024
Conference Coverage
Conference Coverage
04/29/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
04/29/2024
Conference Coverage
Conference Coverage
04/29/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
04/29/2024
Conference Coverage
Conference Coverage
04/29/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
04/29/2024